Soy food intake associates with changes in the metabolome and reduced blood pressure in a gut microbiota dependent manner

Nutr Metab Cardiovasc Dis. 2020 Aug 28;30(9):1500-1511. doi: 10.1016/j.numecd.2020.05.001. Epub 2020 May 18.

Abstract

Background and aims: Consumption of soy foods has been associated with protection against cardiometabolic disease, but the mechanisms are incompletely understood. We hypothesized that habitual soy food consumption associates with gut microbiome composition, metabolite production, and the interaction between diet, microbiota and metabolites.

Methods and results: We analyzed dietary soy intake, plasma and stool metabolites, and gut microbiome data from two independent cross-sectional samples of healthy US individuals (N = 75 lean or overweight, and N = 29 obese). Habitual soy intake associated with several circulating metabolites. There was a significant interaction between soy intake and gut microbiome composition, as defined by gut enterotype, on metabolites in plasma and stool. Soy consumption associated with reduced systolic blood pressure, but only in a subset of individuals defined by their gut microbiome enterotype, suggesting that responsiveness to soy may be dependent on microbiome composition. Soy intake was associated with differences in specific microbial taxa, including two taxa mapping to genus Dialister and Prevotella which appeared to be suppressed by high soy intake We identified context-dependent effects of these taxa, where presence of Prevotella was associated with higher blood pressure and a worse cardiometabolic profile, but only in the absence of Dialister.

Conclusions: The gut microbiome is an important intermediate in the interplay between dietary soy intake and systemic metabolism. Consumption of soy foods may shape the microbiome by suppressing specific taxa, and may protect against hypertension only in individuals with soy-responsive microbiota.

Clinical trials registry: NCT02010359 at clinicaltrials.gov.

Keywords: Blood pressure; Cardiometabolic health; Metabolome; Microbiome; Nutrition; Soy.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers / blood
  • Blood Pressure*
  • Cross-Sectional Studies
  • Energy Metabolism*
  • Feces / chemistry
  • Feces / microbiology
  • Female
  • Gastrointestinal Microbiome*
  • Host-Pathogen Interactions
  • Humans
  • Intestines / microbiology*
  • Male
  • Metabolomics
  • Middle Aged
  • Obesity / blood
  • Obesity / diet therapy*
  • Obesity / microbiology
  • Obesity / physiopathology
  • Pennsylvania
  • Ribotyping
  • Soy Foods*
  • Time Factors
  • Treatment Outcome
  • United States
  • Young Adult

Substances

  • Biomarkers

Associated data

  • ClinicalTrials.gov/NCT02010359